Diametric Capital’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,497
Closed -$485K 398
2024
Q1
$485K Buy
+3,497
New +$440K 0.27% 84
2023
Q4
Sell
-19,708
Closed -$1.84M 296
2023
Q3
$1.84M Buy
+19,708
New +$2.22M 0.77% 29
2023
Q2
Sell
-9,409
Closed -$1.09M 384
2023
Q1
$1.09M Sell
9,409
-2,182
-19% -$244K 0.53% 42
2022
Q4
$1.31M Buy
+11,591
New +$1.27M 0.63% 30
2022
Q3
Sell
-27,047
Closed -$2.02M 273
2022
Q2
$2.02M Buy
27,047
+447
+2% +$40.8K 1.49% 9
2022
Q1
$3.4M Buy
+26,600
New +$2.91M 1.88% 7

Other funds holding DXCM

Diametric Capital's DXCM Position: Q2 2024 in Review

Diametric Capital sold out of DexCom (DXCM) in Q2 2024, closing a stake of 3,497 shares — an estimated $485K sold.

Diametric Capital first reported a position in DXCM in Q1 2022 and held it in 6 quarters. The position peaked at $3.4M in Q1 2022. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Diametric Capital reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Diametric Capital sold 3,497 DexCom shares in Q2 2024, an estimated $485K.
  • Diametric Capital first reported a position in DexCom in Q1 2022 and held it in 6 quarters.
  • Diametric Capital's DexCom position peaked at $3.4M in Q1 2022.
  • 999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Diametric Capital's 13F filing for Q2 2024, filed 13 Aug 2024.